JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.72B |
| 2 |
Amazon
AMZN
|
+$2.99B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.6B |
| 4 |
Mastercard
MA
|
+$1.47B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.62B |
| 2 |
Apple
AAPL
|
+$3.37B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.93B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.93B |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.95% |
| 2 | Healthcare | 10.56% |
| 3 | Financials | 9.04% |
| 4 | Consumer Discretionary | 8.59% |
| 5 | Industrials | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
CALL
Protagonist Therapeutics
PTGX
$10B
| $1.67M | ﹤0.01% |
100,000
-168,000
| -63% | -$3.26M |
|
|
DISH
3527
PUT
DELISTED
DISH Network Corp.
DISH
| $1.67M | ﹤0.01% |
284,600
-13,100
| -4% | -$89.3K |
|
3528
CALL
Rio Tinto
RIO
$156B
| $1.67M | ﹤0.01% |
26,200
| – | – |
|
|
OPI
3529
DELISTED
Office Properties Income Trust
OPI
| $1.67M | ﹤0.01% |
406,340
+270,741
| +200% | +$1.88M |
|
3530
Amylyx Pharmaceuticals
AMLX
$2.41B
| $1.67M | ﹤0.01% |
90,965
-99,331
| -52% | -$2.1M |
|
|
FITB
3531
CALL
Fifth Third Bancorp
FITB
$52.7B
| $1.66M | ﹤0.01% |
65,700
| – | – |
|
3532
Hartford Core Bond ETF
HCRB
$406M
| $1.66M | ﹤0.01% |
+50,061
| New | +$1.71M |
|
|
INVX
3533
Innovex International
INVX
$2.18B
| $1.66M | ﹤0.01% |
58,992
+10,830
| +22% | +$294K |
|
3534
Rhythm Pharmaceuticals
RYTM
$7.95B
| $1.66M | ﹤0.01% |
72,411
+2,823
| +4% | +$63.2K |
|
|
PARAP
3535
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
| $1.65M | ﹤0.01% |
93,217
+16,597
| +22% | +$352K |
|
3536
PUT
ASML
ASML
$708B
| $1.65M | ﹤0.01% |
+2,800
| New | +$1.86M |
|
3537
Hudbay
HBM
$11.9B
| $1.65M | ﹤0.01% |
338,351
-168,078
| -33% | -$852K |
|
3538
Adaptive Biotechnologies
ADPT
$3.94B
| $1.65M | ﹤0.01% |
302,124
-9,072
| -3% | -$60K |
|
|
XYZ
3539
CALL
Block Inc
XYZ
$49.8B
| $1.65M | ﹤0.01% |
37,200
+24,300
| +188% | +$1.5M |
|
3540
DMC Global
BOOM
$155M
| $1.64M | ﹤0.01% |
67,158
+5,975
| +10% | +$130K |
|
3541
First Trust Municipal High Income ETF
FMHI
$1.01B
| $1.64M | ﹤0.01% |
+36,425
| New | +$1.7M |
|
3542
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.14B
| $1.64M | ﹤0.01% |
17,389
+6,860
| +65% | +$681K |
|
3543
Lufax Holding
LU
$1.3B
| $1.64M | ﹤0.01% |
386,649
-119,118
| -24% | -$660K |
|
|
NGD
3544
DELISTED
New Gold Inc
NGD
| $1.63M | ﹤0.01% |
1,792,318
-3,173,045
| -64% | -$3.38M |
|
|
SASR
3545
DELISTED
Sandy Spring Bancorp Inc
SASR
| $1.63M | ﹤0.01% |
76,054
-5,568
| -7% | -$127K |
|
3546
Invesco S&P SmallCap Health Care ETF
PSCH
$173M
| $1.63M | ﹤0.01% |
43,373
+938
| +2% | +$39.1K |
|
3547
PC Connection
CNXN
$2.05B
| $1.62M | ﹤0.01% |
30,392
+3,944
| +15% | +$200K |
|
|
NVEE
3548
DELISTED
NV5 Global
NVEE
| $1.62M | ﹤0.01% |
67,412
-7,596
| -10% | -$196K |
|
3549
Crinetics Pharmaceuticals
CRNX
$8.99B
| $1.62M | ﹤0.01% |
54,430
+10,756
| +25% | +$222K |
|
3550
Innovator US Equity Power Buffer ETF February
PFEB
$926M
| $1.62M | ﹤0.01% |
53,036
+46,564
| +719% | +$1.44M |
|
Similar funds
JP Morgan Chase's Q3 2023 Portfolio in Review
As of Q3 2023, JP Morgan Chase held 7,912 positions worth $906B, down 1.5% from $920B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
JP Morgan Chase's Q3 2023 filing shows 1,013 new, 2,454 increased, 3,092 reduced and 490 closed positions. Its largest new stake was JPMorgan Global Select Equity ETF: 18,266,376 shares worth $849M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.62B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q3 2023 buy was JPMorgan Global Select Equity ETF: 18,266,376 shares worth $849M.
- JP Morgan Chase added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $3.72B increase.
- JP Morgan Chase's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.62B.
- JP Morgan Chase fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $314M.
- JP Morgan Chase's ten largest holdings make up 19% of its $906B portfolio in Q3 2023.
- JP Morgan Chase opened 1,013 new positions and closed 490 in Q3 2023.
- JP Morgan Chase's portfolio value fell 1.5% quarter-over-quarter to $906B.
Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.